<unk>  is a glucagon-like peptide 1 (GLP-1) receptor agonist that is FDA approved for the adjunction of diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, vomiting, diarrhea, abdominal pain and constipation.
Semaglutide
Albiglutide
Teduglutide
Dulaglutide
Liraglutide
Linagliptin
Exenatide
Saxagliptin